This inventor holds 3 USPTO granted patents, plus 1 CIPO patent and 3 EPO patents. Top assignees: Lipid Systems Sp. Z.o.o., Uniwersytet Jagielloński. Active years: 2022-2026.
Company Filing History:
Years Active: 2022-2026
Title: Marek Langner: Innovator in Liposomal Technology
Introduction
Marek Langner is a notable inventor based in Wroclaw, Poland. He has made significant contributions to the field of liposomal technology, particularly in the encapsulation of hydrophilic compounds. With a total of 3 patents to his name, Langner's work is paving the way for advancements in various applications, including pharmaceuticals and cosmetics.
Latest Patents
Langner's latest patents focus on the high-efficiency encapsulation of hydrophilic compounds in unilamellar liposomes. This innovative process utilizes polyhydric alcohols, such as propylene glycol or glycerine, to dissolve hydrophobic compounds that form the lipid bilayer of the liposomes. The invention not only provides unilamellar liposomes (UL) but also outlines a method for their preparation through low-temperature extrusion. These UL have potential applications in the manufacturing of medicaments, cosmetic products, food additives, and disinfectants.
Career Highlights
Throughout his career, Marek Langner has worked with various organizations, including Lipid Systems Sp. z o.o. and Jagiellonian University. His experience in these institutions has allowed him to refine his expertise in liposomal technology and contribute to groundbreaking research.
Collaborations
Langner has collaborated with several professionals in his field, including Magdalena Przybylo and Tomasz Borowik. These partnerships have further enhanced his research and development efforts in liposomal applications.
Conclusion
Marek Langner's innovative work in the encapsulation of hydrophilic compounds demonstrates his commitment to advancing liposomal technology. His contributions are expected to have a lasting impact on various industries, including healthcare and cosmetics.